Commercial Systems Architecture for Pharma & Life Sciences.
New Title
The Customer Excellence Partner
for Pharma Provocateurs.
Because Pharma's Consumer-Grade Future is Already Here.
What's Your Move?
The Shift
With Experiential Commerce, Consumer-Grade Isn't an Ideology. It's a Commercial Imperative.
Healthcare professionals are also high expectation consumers in their "Other Life."
The global pharma industry must face an irrefutable truth: HCPs are consumers too. Trained by brand experiences with leading consumer brands in their everyday lives, they bring those same expectations of ease, relevance, and simplicity into their professional lives.
Prescribing decisions are increasingly shaped by experiential attributes.
35% of prescribing decisions are now shaped by HCPs’ experiences with pharma (DT Consulting), yet 62% feel overwhelmed by pharma engagement (Indegene). Like 74% of consumers, how likely are they to leave a brand after three or fewer negative experiences? (Salesforce).
Experience now drives whether value is fully realized as patient and commercial impact.
It governs how prescribing intent progresses across access, fulfillment, and adherence, shaping the ease and continuity of the journey, and ultimately determining whether intent becomes patient outcomes and realized commercial value, or is lost to friction and fragmentation.
Consumer-Grade Exposes a Multi-Dimensional Problem
Pharma Doesn't Have a Demand Problem. It Has a Value Realization Problem.
The Consumer-Grade gap is driving systemic value leakage, degrading both patient outcomes and commercial performance. Brand investment creates demand. Field execution wins interactions. Then the value quietly leaks away, at the handoffs, the unmeasured moments, the points of friction, and the loops that never close.
Pharma Built the Intent Engine. It Never Built the Value Realization System.
Pharma has engineered the front end with extraordinary rigor: segmentation, targeting, CRM, incentives, access strategy, and now AI.
But after the script is written, the system fragments. Patient services, hubs, specialty pharmacy, access, adherence, reimbursement, and field teams operate across disconnected data, metrics, and ownership.
This Has Created a Multi-Billion Dollar Blindspot in Pharma Companies.
Pharma’s blindspot begins after the script is earned. The financial hit is massive, but the visibility is minimal. Investment has already been made to generate demand and win intent. But when patients do not start, stay, and benefit, that value never fully realizes. It becomes hidden financial exposure, across the journey and invisible as a connected risk.
The Commercial Question, and the C-Suite Imperative, Is No Longer Whether Pharma Can Create Intent. It Is Whether the Organization Can See, Own, and Convert That Intent Into Realized Value.
The Commercial System Wasn't Built for This.
Customer Excellence Is.
I’m Wayne Simmons.
I Help Pharma Organizations Architect the Consumer-Grade Commercial Systems That Turn Investment Into Fully Realized Value.
Former Pfizer & Bayer Commercial & Customer Experience Leader | Author, Customer Excellence Enterprise (Wiley)
Many pharma commercial systems were built to generate a different outcome. Influencing prescribing intent mattered more than ensuring that intent translated into realized patient and commercial impact.
Informed by first of a kind leadership roles at Pfizer and Bayer, and shaped by two decades working in and alongside iconic consumer brands, I have delivered 30% brand growth post-relaunch, upskilled thousands of commercial colleagues, and deployed customer-centric operating models to over 100 markets. I now help pharma and life sciences organizations embed experience into their commercial system, operationalizing the discipline of customer excellence as a strategic commercial discipline and value lever.
Through Customer Excellence Activation, I partner with organizations navigating high stakes transformation to build the experience-driven, consumer-grade commercial systems, operational behaviors, and enterprise capabilities required to improve value realization and sustain differentiated customer experiences at scale.
Let’s Get to Work.
The Foundation
Shaped by the Iconic Brands That Set the Consumer-Grade Standard. Sharpened Inside Pfizer and Bayer.
The Formula
Solving the Value Leakage Problem
Doesn't Happen By Accident. It Has a Formula.
Value Realization =
(Brand×Product×Experience)Cultureⁿ× (1−CVaR)
(Brand: the equity. Product: the asset. Experience: the differentiator. Culture: the compounding force. Customer Value at Risk: the drag)
The System
The System Operationalizes the Formula Through Three Integrated Stages.
The System is the commercial methodology that moves an organization from leakage visibility through acute intervention to a permanent state of continuous intelligence. It does not begin with transformation. It begins with evidence, because no leader who is actively losing value will commit to operating model redesign as the entry point.
Value leakage is made visible and quantified through a data-driven diagnostic, and conviction is built through evidence.
The organization is engaged to ideate and deploy acute interventions, with baseline field signals generating the insights.
Signal collection is made ongoing, and barrier identification and mitigation are embedded into permanent ways of working.
The Solution
FieldXOS Turns Field Intelligence Into Systemic Value Realization at Scale.
FieldXOS is the AI powered field intelligence and activation operating system built for pharma's value realization problem. It embeds journey operations into field enablement so prescribing intent progresses through access, fulfillment, initiation, and adherence instead of leaking between them.
Every FieldXOS Engagement Begins With a 3-4 Week Value Leakage Diagnostic. Board-Ready. Yours to Keep Regardless of What Comes Next.
Track Record Snapshot
Integrating The Formula Into the Commercial System Through Delivers Real Results.
Brand Launch Recovery
12% NBRx Brand
Growth Turnaround
Stalled high-priority launch restored to growth
trajectory without added promotional intensity.
Field Force Rewired
Field-led 30+% Brand
Revenue Uplift
Frontline and HCP experiential feedbck operationalized into enterprise field force ways of working.
Omnichannel Activation
100+ Markets Rewired
with VoC Signals
Signal-driven commercial improvements implemented across digital, field, and DTC channels.
Media Mentions
Featured in Media Conversations on Customer Excellence and Commercial Transformation in Pharma.
Pfizer Has a New Playbook for Reviving Sales—and It’s Starting to Pay Off.
Drugmaker has revamped how it packages, promotes, and sells certain medicines in bid to overcome post-pandemic slump.
By Jared S. Hopkins
How Pfizer Is Building Customer Experience From the Inside Out.
An exclusive interview with Pfizer’s Wayne Simmons on reshaping customer experience by listening to those interacting with healthcare professionals.
By Dom Nicastro
The Book
Practiced. Proven. Published. Codifying the Commercial Discipline of Customer Excellence.
Customer Excellence did not exist as a defined body of work. I partnered with a fellow founding faculty member of the master's program in Customer Experience Management at Michigan State University to codify it. Wiley published the result. The Customer Excellence Enterprise is a structural and systemic approach to embedding customer centricity and customer experience into the enterprise itself, designed to close the gap between intent and impact in a consumer-grade world. Now adopted in graduate programs and enterprise capability programs.
